Targeting glucocorticoid signalling in dendritic cells for glioblastoma treatment
Qiuchen Zhao, Jhuma Pramanik, Arif Jabbar…·Bidesh Mahata
This study identifies glucocorticoid signalling as a barrier to dendritic cell immunotherapy in glioblastoma and shows that targeting NR3C1 can restore DC function and enhance anti-tumor responses.